Insider filing · EWTX
Alan J Russell
Chief Scientific Officer
profile →
Edgewise Therapeutics, Inc.
EWTX · Healthcare · 28 filings in 24 months
ticker →
Alan J Russell sold $2.1M of Edgewise Therapeutics (EWTX)
Executed Sep 20 2024, disclosed Sep 24 2024, 4 days later.
Value, as filed
$2.1M
74,185 sh × $28.25
Executed
Sep 20 2024
the trade date, as filed
Disclosed
Sep 24 2024
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ARAlan J Russell (Chief Scientific Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Edgewise Therapeutics, Inc. (EWTX). The largest single filing was $7.9M of EWTX (200,000 sh across 2 lots, as filed), executed Jul 1.
The name
EWTXHealthcare · Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle dis…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Alan J Russell in EWTX
EWTXSALE
Edgewise Therapeutics, Inc.
$141K3,238 sh × $43.68
Exec Aug 12
Filed Aug 14 · 4:53 PM ET EWTXSALE Edgewise Therapeutics, Inc. $7.9M
200,000 sh across 2 lots
Exec Jul 1
Filed Jul 2 · 5:21 PM ET EWTXSALE Edgewise Therapeutics, Inc. $2.1M
100,000 sh × $21.12
Exec Nov 12 2025
Filed Nov 13 2025 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. $1.5M
100,000 sh × $14.60
Exec Aug 26 2025
Filed Aug 28 2025 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. $241K
8,015 sh × $30.02
Exec Feb 5 2025
Filed Feb 7 2025 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. $2.7M
100,000 sh × $27.37
Exec Dec 30 2024
Filed Dec 31 2024 · 5:30 PM ET